Tandem Diabetes Care (TNDM) Retained Earnings (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Retained Earnings came in at $5.0 million in Q1 2026, up 100.43% YoY from $2.5 million in Q1 2025, and up 100.4% on a QoQ basis from -$1.3 billion in Q4 2025.
Tandem Diabetes Care (TNDM) Retained Earnings (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Retained Earnings data on file, last reported at $5.0 million in Q1 2026.
- Quarterly Retained Earnings rose 100.43% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 100.43% YoY) and the FY2025 annual result came in at -$1.3 billion, down 64231.54% from the prior year.
- Retained Earnings rose to $5.0 million in Q1 2026, from -$1.3 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $5.2 million in Q3 2025 to a low of -$1.3 billion in Q4 2025.
- A 5-year average of -$475.0 million and a median of -$649.3 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings slumped 2291017.24% — and 2025, when it jumped 398.88%.
- Tracing TNDM's Retained Earnings over 5 years: stood at -$729.2 million in 2022, then soared by 100.19% to $1.4 million in 2023, then slumped by 242.22% to -$1.9 million in 2024, then slumped by 64231.54% to -$1.3 billion in 2025, then surged by 100.4% to $5.0 million in 2026.
- The last three Retained Earnings figures came in at $5.0 million (Q1 2026), -$1.3 billion (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 21.82 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 32.64 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 7.82 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 14.86 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 2.88 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 6.78 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Tandem Diabetes Care | 1.57 Bn | 1.11 Bn | 144.78 Mn | -1.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.29 Bn |
| Mar 31, 2026 | 5.04 Mn |
| Dec 31, 2025 | -1.25 Bn |
| Sep 30, 2025 | 5.17 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Mar 31, 2025 | -1.18 Bn |
| Dec 31, 2024 | -1.95 Mn |
| Sep 30, 2024 | -1.05 Bn |
| Jun 30, 2024 | -1.25 Mn |
| Mar 31, 2024 | -994.52 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | -2.21 Mn |
| Jun 30, 2023 | -1.19 Mn |
| Mar 31, 2023 | -853.06 Mn |
| Dec 31, 2022 | -729.19 Mn |
| Sep 30, 2022 | -713.34 Mn |
| Jun 30, 2022 | -664.37 Mn |
| Mar 31, 2022 | -649.31 Mn |
| Dec 31, 2021 | -616,000.00 |
| Sep 30, 2021 | -645.40 Mn |